Just download the older, free version from the developer's website and then drag ClamXav to your Applications folder. This does have a marked effect on how fast applications operate in the virtual environment, so your experience may differ from mine. Because I use live malware in my testing, I install the antivirus software I am evaluating in a virtual environment. In my testing, I used an Apple iMac running OS X 10.10 Yosemite. Also, please note that the version currently available in the Apple App store (2.6) is much older than the one reviewed here (2.7.5). It's always a good idea to use the latest version of software-especially security software-so use at your own risk. Users can download 2.7.5 for free from the ClamXav website, but Allan says that although it will still receive new virus definitions, it will not receive other software updates, and may not be compatible with future updates of OS X. SEE ALSO: The Best Free Antivirus Protection for 2020 I'll be reviewing the new version of ClamXav soon, but I'm splitting off this review of version 2.7.5 for the benefit users unwilling, or unable, to pay for the new version of the software. From version 2.8 on, ClamXav is being offered for $29.95 for a non-commercial license and distributed by Canimaan Software Ltd.
A new always-on, always-watching ClamXav Sentry application does a lot to modernize the app, but a counterintuitive interface and low independent lab scores make it hard to recommend.Ī note before continuing: In June 2015, ClamXav, which has been offered for free by developer Frank Allan since 2004, moved to a for-pay model. A long-available and free antivirus application, ClamXav says that it will defend your Mac from all harm. That same user has probably gone looking for Mac antivirus, and almost certainly stumbled across the famous Mac security app ClamXav. The savvy Mac user knows that his or her computer isn't impervious to attack.
ClamXav 2.7 is the last free edition of the storied Mac antivirus app, but it fails to impress with an unintuitive interface and poor independent lab scores.